Abstract
Objectives
This study aimed to evaluate the oral findings and dentomaxillofacial involvement of patients diagnosed with Type I Gaucher Disease (GD), and to compare these findings with the control group.
Methods
A total of 32 patients, 5 males, and 11 females in both the study (range 19–60, mean age 34.56) and control group (range 18–49, mean age 34.63) were included in the study. The file records of all patients obtained in the first evaluation were examined, and the hematological, visceral, and bone examination findings were recorded. Subsequently, oral examinations were performed for oral findings and dentomaxillofacial involvement, and radiological examinations were performed in panoramic images and cone-beam computed tomography (CBCT) images.
Results
There was mandible involvement in 9 (56.3%), and involvement in both jaws in 4 (25.0%) of the patients with Type I GD. According to the CBCT findings, generalized rarefaction in 10 (62.5%) patients, enlarged marrow spaces in 12 (75.0%) patients, thinning of the lamina dura in 10 (62.5%) patients, and loss in the cortical borders of the mandibular canal in 7 (43.8%) patients were among the common radiographic findings. When the control and study group were compared, in panoramic images, a significant difference was found in terms of generalized rarefaction and enlarged marrow spaces, while significant differences were found in CBCT images regarding generalized rarefaction, enlarged marrow spaces, loss in the cortical margins of the mandibular canal and widening in the periodontal ligament space.
Conclusions
The roadmap for the diagnosis of Gaucher lesions in the jawbones includes a comprehensive medical history and a clinical and radiological examination. In conclusion, dentists should be familiar with the dentomaxillofacial findings of GD and be aware of possible oral and dental complications that may develop.
Similar content being viewed by others
References
Gaucher P. De l'épithélioma primitif de la rate. MD Thèse, Faculté de Médecine de Paris; 1882.
Grabowski GA, Zimran A, Ida H. Gaucher disease types 1 and 3: Phenotypic characterization of large populations from the ICGG Gaucher Registry. Am J Hematol. 2015;90:12–8.
Grabowski GA. Phenotype, diagnosis, and treatment of Gaucher’s disease. Lancet. 2008;372:1263–71.
Saudubray J-M, Garcia-Cazorla A. Clinical approach to inborn errors of metabolism in pediatrics In: Proceedings of the Inborn metabolic diseases. Springer; 2016. pp. 3–70.
Mikosch P, Hughes D. An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr. 2010;160:609–24.
Zimran A, Kay A, Gelbart T, Garver P, Thurston D, Saven A, et al. Gaucher disease: clinical, laboratory, radiologic, and genetic features of 53 patients. Medicine. 1992;71:337–53.
Cremin B, Davey H, Goldblatt J. Skeletal complications of type I Gaucher disease: the magnetic resonance features. Clin Radiol. 1990;41:244–7.
Sales J, Hunt A. Gaucher’s disease and portal hypertension. Br J Surg. 1970;57:225–8.
Medoff AS, Bayrd ED. Gaucher’s disease in 29 cases: hematologic complications and effect of splenectomy. Ann Intern Med. 1954;40:481–92.
James S, Stromeyer F, Stowens D, Barranger J. Gaucher disease: hepatic abnormalities in 25 patients. Prog Clin Biol Res. 1982;95:131–42.
Bender I. Dental observations in Gaucher’s disease. J Dent Res. 1938;17:359–69.
Sela J, Polliack A, Ulmansky M. Involvement of the mandible in Gaucher’s disease: report of a case with post-mortem findings. Br J Oral Surg. 1971;9:246–50.
Hall MB, Brown RW, Baughman RA. Gaucher’s disease affecting the mandible. J Oral Maxillofac Surg. 1985;43:210–3.
Schwartz MR, Weycer JS, McGavran MH. Gaucher’s disease involving the maxillary sinuses. Arch Otolaryngol Head Neck Surg. 1988;114:203–6.
Lustmann J, Ben-Yehuda D, Somer M, Ulmansky M. Gaucher’s disease affecting the mandible and maxilla: report of a case. Int J Oral Maxillofac Surg. 1991;20:7–8.
Heasman P. Mandibular lesions in Gaucher disease. Oral Surg Oral Med Oral Pathol. 1991;72:506.
Regenye GR, Huberman BA, Itkin AB. Gaucher’s disease: Case report of mandibular trauma. Oral Surg Oral Med Oral Pathol. 1992;73:23–6.
Bender I, Bender A. Dental observations in Gaucher’s disease: review of the literature and two case reports with 13-and 60-year follow-ups. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;82:650–9.
Karabulut N, Ahmetoglu A, Ariyürek M, Erol C, Gürakan F. Obliteration of maxillary and sphenoid sinuses in Gaucher’s disease. Br J Radiol. 1997;70:533–5.
Horwitz J, Hirsh I, Machtei EE. Oral aspects of Gaucher’s disease: a literature review and case report. J Periodontol. 2007;78:783–8.
Lisboa GM, de Guedes VL. Exodontia in patient with Gaucher’s disease. Rev Bras Hematol Hemoter. 2011;33:481–2.
Zeevi I, Anavi Y, Kaplan I, Zadik Y. Jaws features in Type 1 Gaucher disease. J Oral Maxillofac Surg. 2013;71:694–701.
Ahmadieh A, Farnad F, Sedghizadeh PP. Gaucher disease with jawbone involvement: a case report. J Med Case Rep. 2014;8:360.
Watanabe PCA, Santos E, Faria V, Watanabe P. Literature review: dental aspects in gaucher disease. Int J Odontostomat. 2018;12:147–51.
Saranjam HR, Sidransky E, Levine WZ, Zimran A, Elstein D. Mandibular and dental manifestations of Gaucher disease. Oral Dis. 2012;18:421–9.
Carter LC, Fischman SL, Mann J, Elstein D, Stabholz A, Zimran A. The nature and extent of jaw involvement in Gaucher disease: observations in a series of 28 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:233–9.
Fischman SL, Elstein D, Sgan-Cohen H, Mann J, Zimran A. Dental profile of patients with Gaucher disease. BMC Oral Health. 2003;3:4.
Givol N, Goldstein G, Peleg O, Shenkman B, Zimran A, Elstein D, et al. Thrombocytopenia and bleeding in dental procedures of patients with Gaucher disease. Haemophilia. 2012;18:117–21.
Nobre R, Ribeiro A, Alves-Junior S, Tuji F, Das Rodrigues Pinheiro MG, Pinheiro L, et al. Dentomaxillofacial manifestations of Gaucher’s disease: preliminary clinical and radiographic findings. Dentomaxillofac Radiol. 2012;41:541–7.
Brady RO, Kanfer JN, Shapiro D. Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem Biophys Res Commun. 1965;18:221–5.
Lukina E, Watman N, Arreguin EA, Dragosky M, Iastrebner M, Rosenbaum H, et al. Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 study. Blood. 2010;116:4095–8.
Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998;273:25680–5.
Rosenthal DI, Doppelt SH, Mankin HJ, Dambrosia JM, Xavier RJ, McKusick KA, et al. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics. 1995;96:629–37.
Elstein D, Hadas-Halpern I, Itzchaki M, Lahad A, Abrahamov A. Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement. Blood Cells Mol Dis. 1996;22:104–11.
Itzchaki M, Lebel E, Dweck A, Patlas M, Hadas-Halpern I, Zimran A, et al. Orthopedic considerations in Gaucher disease since the advent of enzyme replacement therapy. Acta Orthop Scand. 2004;75:641–53.
Pastores GM, Weinreb NJ, Aerts H, Andria G, Cox TM, Giralt M, et al. Therapeutic goals in the treatment of Gaucher disease. In: Proceedings of the Seminars in hematology. Elsevier, pp 4–14.
Grabowski GA, Barton NW, Pastores G, Dambrosia JM, Banerjee TK, McKee MA, et al. Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources. Ann Intern Med. 1995;122:33–9.
Mohamed YSA, Zayet MK, Omar OM, El-Beshlawy AM. Jaw bones’ involvement and dental features of type I and type III Gaucher disease: a radiographic study of 42 paediatric patients. Eur Arch Paediatr Dent. 2020;21:241–7.
Serratrice C, Carballo S, Serratrice J, Stirnemann J. Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy. Core Evid. 2016;11:37.
Rasmusson L, Abtahi J. Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment. Int J Dent. 2014;2014:471035.
Browne WG. Oral pigmentation and root resorption in Gaucher’s disease. J Oral Surg. 1977;35:153–5.
Bildman B, Martinez M Jr, Robinson LH. Gaucher’s disease discovered by mandibular biopsy: report of case. J Oral Surg. 1972;30:510–2.
Weigler JM, Seldin R, Minkowitz S. Gaucher’s disease involving the mandible: report of case. J Oral Surg. 1967;25:158–63.
Michanowicz AE, Michanowicz JP, Stein GM. Gaucher’s disease. Report of a case. Oral Surg Oral Med Oral Pathol. 1967;23:36–42.
Spiegel LH. Gaucher’s disease. Oral Surg Oral Med Oral Pathol. 1957;10:158–66.
Kumar NS, John RR, Rethish E. Relatively rare entity of avascular necrosis of maxillary bone caused by gaucher’s disease—a case report. J Oral Maxillofac Surg. 2012;70:2590–5.
Wenstrup R, Roca-Espiau M, Weinreb N, Bembi B. Skeletal aspects of Gaucher disease: a review. Br J Radiol. 2002;75:A2–12.
Wasserstein MP, Martignetti JA, Zeitlin R, Lumerman H, Solomon M, Grace ME, et al. Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation. Am J Med Genet. 1999;84:334–9.
Bender I. Dental observations in Gaucher’s disease: A twenty-year follow-up. Oral Surg Oral Med Oral Pathol. 1959;12:546–61.
Zadik Y, Aktaş A, Drucker S, Nitzan DW. Aneurysmal bone cyst of mandibular condyle: a case report and review of the literature. J Craniomaxillofac Surg. 2012;40:e243–8.
Zadik Y, Yitschaky O, Neuman T, Nitzan DW. On the self-resolution nature of the buccal bifurcation cyst. J Oral Maxillofac Surg. 2011;69:e282–4.
Chikui T, Yonetsu K, Yoshiura K, Miwa K, Kanda S, Ozeki S, et al. Imaging findings of lipomas in the orofacial region with CT, US, and MRI. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84:88–95.
Goldman H. Gaucher’s disease. Compendium (Newtown, Pa). 1988;9:42–3.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by FA, HD, EMC and FB. The first draft of the manuscript was written by FA] and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
Informed consent
Informed consent was obtained from all patients for being included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aşantoğrol, F., Dursun, H., Canger, E.M. et al. Clinical and radiological evaluation of dentomaxillofacial involvement in Type I Gaucher disease. Oral Radiol 38, 210–223 (2022). https://doi.org/10.1007/s11282-021-00546-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11282-021-00546-2